within Pharmacolibrary.Drugs.ATC.C;

model C03DA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.69,
    Cl             = 0.00018,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0436,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.012116666666666666,
    Tlag           = 10.020000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C03DA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Eplerenone is a selective aldosterone receptor antagonist used primarily for the treatment of hypertension and heart failure. It blocks the effects of aldosterone on the kidneys, promoting the excretion of sodium and water while retaining potassium. The drug is approved and widely used in clinical practice for managing cardiovascular conditions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult male volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Cook, CS, et al., &amp; Liu, NW (2003). Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 31(11) 1448–1455. DOI:<a href=&quot;https://doi.org/10.1124/dmd.31.11.1448&quot;>10.1124/dmd.31.11.1448</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14570778/&quot;>https://pubmed.ncbi.nlm.nih.gov/14570778</a></p></li><li><p>Chen, J, et al., &amp; Ruan, Z (2016). Dose Proportionality and Pharmacokinetics of Eplerenone in Healthy Chinese Subjects. <i>Drug research</i> 66(3) 154–159. DOI:<a href=&quot;https://doi.org/10.1055/s-0035-1559623&quot;>10.1055/s-0035-1559623</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26262771/&quot;>https://pubmed.ncbi.nlm.nih.gov/26262771</a></p></li><li><p>Oishi, M, et al., &amp; Sweeney, K (2017). Population Pharmacokinetics of Eplerenone in Japanese Patients With Chronic Heart Failure. <i>Journal of clinical pharmacology</i> 57(6) 730–738. DOI:<a href=&quot;https://doi.org/10.1002/jcph.861&quot;>10.1002/jcph.861</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28032902/&quot;>https://pubmed.ncbi.nlm.nih.gov/28032902</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C03DA04;
